Jing Peng

3.2k total citations · 1 hit paper
77 papers, 2.5k citations indexed

About

Jing Peng is a scholar working on Molecular Biology, Cancer Research and Immunology. According to data from OpenAlex, Jing Peng has authored 77 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 50 papers in Molecular Biology, 33 papers in Cancer Research and 11 papers in Immunology. Recurrent topics in Jing Peng's work include Cancer-related molecular mechanisms research (15 papers), MicroRNA in disease regulation (14 papers) and RNA modifications and cancer (12 papers). Jing Peng is often cited by papers focused on Cancer-related molecular mechanisms research (15 papers), MicroRNA in disease regulation (14 papers) and RNA modifications and cancer (12 papers). Jing Peng collaborates with scholars based in China, United States and France. Jing Peng's co-authors include Mark Merchant, Hartmut Koeppen, Richard M. Neve, Elicia Penuel, Timothy R. Wilson, Yulei Wang, Jeff Sosman, Yibing Yan, John G. Moffat and Antoni Ribas and has published in prestigious journals such as Nature, Advanced Materials and Journal of Clinical Oncology.

In The Last Decade

Jing Peng

71 papers receiving 2.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Widespread potential for growth-factor-driven resistance to anticancer kinase inhibitors

2012 884 citations Jing Peng, Mark Merchant et al. profile →

Peers

Jing Peng

ONCOL

PRM

IMMUN

Ling‐Wen Ding Singapore

Vijay Pandey China

Olivier Dormond Switzerland

Qiong Wu China

Christine Pirker Austria

Jiaxin Liang China

Lacey E. Dobrolecki United States

Kenneth W. Yip Canada

Minhua Zheng China

Ling‐Wen Ding Singapore

Jing Peng

1.6k ×1.0

506 ×0.7

ONCOL

541 ×0.9

318 ×1.1

PRM

260 ×1.1

IMMUN

Citations per year, relative to Jing Peng Jing Peng (= 1×) peers Ling‐Wen Ding

Countries citing papers authored by Jing Peng

Since Specialization

Citations

This map shows the geographic impact of Jing Peng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jing Peng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jing Peng more than expected).

Fields of papers citing papers by Jing Peng

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jing Peng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jing Peng. The network helps show where Jing Peng may publish in the future.

Co-authorship network of co-authors of Jing Peng

This figure shows the co-authorship network connecting the top 25 collaborators of Jing Peng. A scholar is included among the top collaborators of Jing Peng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jing Peng. Jing Peng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Peng, Jing, et al.. (2025). Evolution-assisted engineering of E. coli improved succinic acid production from glycerol. PubMed. 7(2). 100022–100022. 2 indexed citations

Khan, Muhammad Musa, Yihan Li, Fengliang Jin, et al.. (2025). Disruption of midgut homeostasis by microplastics in Spodoptera frugiperda: Insights into inflammatory and oxidative mechanisms. Journal of Hazardous Materials. 487. 137262–137262. 8 indexed citations

Peng, Jing, et al.. (2025). 1,25(OH)₂D₃ inhibits ferroptosis in nucleus pulposus cells via VDR signaling to mitigate lumbar intervertebral disc degeneration. Scientific Reports. 15(1). 7968–7968.

Liang, Huichun, Fubing Li, Huan Fang, et al.. (2025). A novel peptide 66CTG stabilizes Myc proto-oncogene protein to promote triple-negative breast cancer growth. Signal Transduction and Targeted Therapy. 10(1). 217–217.

Peng, Jing, et al.. (2024). Upregulation of collagen type X alpha 1 promotes the progress of triple‐negative breast cancer via Wnt/β‐catenin signaling. Molecular Carcinogenesis. 63(8). 1588–1598. 3 indexed citations

Wang, Sibo, Tongtong Yang, Yi Bao, et al.. (2024). Association of serum creatinine-cystatin C ratio with all-cause, cardiovascular and cancer mortality in US adults: a nationwide cohort study. BMC Geriatrics. 24(1). 963–963. 6 indexed citations

Ji, Jun, et al.. (2023). Circ_0068631 sponges miR‐139‐5p to promote the growth and metastasis of cutaneous squamous cell carcinoma by upregulating HOXB7. Skin Research and Technology. 29(2). e13248–e13248. 3 indexed citations

Jiang, Xinhang, Liping Chen, Chen Shen, et al.. (2023). Moderate body lipid accumulation in mice attenuated benzene-induced hematotoxicity via acceleration of benzene metabolism and clearance. Environment International. 178. 108113–108113. 6 indexed citations

Sha, Rui, Ziping Wu, Yaqian Xu, et al.. (2021). Predictive value of lncRNA LOC100505851 in breast cancer in the neoadjuvant setting. Gland Surgery. 10(6). 1899–1909. 2 indexed citations

10.

Yin, Feifei, et al.. (2020). High Expression of CD44 Predicts a Poor Prognosis in Glioblastomas. SHILAP Revista de lepidopterología. 2 indexed citations

11.

Peng, Jing, Jianguo Zhao, Peihong Wu, et al.. (2020). HeLa Cell-Derived Paclitaxel-Loaded Microparticles Efficiently Inhibit the Growth of Cervical Carcinoma. SHILAP Revista de lepidopterología.

12.

Guo, Wei, Guang Chen, Wencan Li, et al.. (2020). Lnc-MCEI mediated the chemosensitivity of esophageal squamous cell carcinoma via miR-6759-5p to competitively regulate IGF2. International Journal of Biological Sciences. 16(15). 2938–2950. 14 indexed citations

13.

Sun, Xiaoxi, et al.. (2016). LukS-PV induces differentiation by activating the ERK signaling pathway and c-JUN/c-FOS in human acute myeloid leukemia cells. The International Journal of Biochemistry & Cell Biology. 76. 107–114. 13 indexed citations

14.

Yin, Yiyuan, Stevan Djakovic, Scot A. Marsters, et al.. (2015). Redesigning a Monospecific Anti-FGFR3 Antibody to Add Selectivity for FGFR2 and Expand Antitumor Activity. Molecular Cancer Therapeutics. 14(10). 2270–2278. 6 indexed citations

15.

Peng, Jing, Xinlian Chen, Qian Hu, et al.. (2014). 1-calcium phosphate-uracil, a synthesized pyrimidine derivative agent, has anti-proliferative, pro-apoptotic and anti-invasion effects on multiple tumor cell lines. Molecular Medicine Reports. 10(5). 2271–2278. 5 indexed citations

16.

Peng, Jing, Qian Hu, Weiping Liu, et al.. (2013). USP9X expression correlates with tumor progression and poor prognosis in esophageal squamous cell carcinoma. Diagnostic Pathology. 8(1). 177–177. 54 indexed citations

17.

Meireles, Sibele I., Roberto Hirata, Suraj Peri, et al.. (2010). Early Changes in Gene Expression Induced by Tobacco Smoke: Evidence for the Importance of Estrogen within Lung Tissue. Cancer Prevention Research. 3(6). 707–717. 49 indexed citations

18.

Peng, Jing, Surojeet Sengupta, & V. Craig Jordan. (2009). Potential of Selective Estrogen Receptor Modulators as Treatments and Preventives of Breast Cancer. Anti-Cancer Agents in Medicinal Chemistry. 9(5). 481–499. 110 indexed citations

19.

Menezes, Daniel E. Lopes de, Jing Peng, Evelyn N. Garrett, et al.. (2005). Multitargeted kinase inhibition and sustained biological effects of CHIR-258 contribute to enhanced preclinical efficacy. Cancer Research. 65. 160–160. 1 indexed citations

20.

Peng, Jing & Daniel R. Schoenberg. (2005). mRNA with a <20-nt poly(A) tail imparted by the poly(A)-limiting element is translated as efficiently in vivo as long poly(A) mRNA. RNA. 11(7). 1131–1140. 33 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact